West Pharmaceutical Services Stock Price, News & Analysis (NYSE:WST)

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

West Pharmaceutical Services announced a quarterly dividend on Thursday, July 25th. Investors of record on Wednesday, October 23rd will be given a dividend of $0.15 per share on Wednesday, November 6th. This represents a $0.60 annualized dividend and a yield of 0.43%. The ex-dividend date of this dividend is Tuesday, October 22nd. View West Pharmaceutical Services' Dividend History.

West Pharmaceutical Services announced that its board has initiated a stock repurchase program on Thursday, February 15th 2018, which permits the company to repurchase 800,000 shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are usually an indication that the company's leadership believes its shares are undervalued.

West Pharmaceutical Services Inc. (NYSE:WST) announced its quarterly earnings data on Thursday, July, 25th. The medical instruments supplier reported $0.89 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.17. The medical instruments supplier earned $469.70 million during the quarter, compared to analyst estimates of $459.90 million. West Pharmaceutical Services had a net margin of 12.94% and a return on equity of 16.93%. The business's revenue was up 5.0% compared to the same quarter last year. During the same period last year, the company posted $0.70 earnings per share. View West Pharmaceutical Services' Earnings History.

West Pharmaceutical Services is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for West Pharmaceutical Services.

West Pharmaceutical Services will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

West Pharmaceutical Services updated its FY19 earnings guidance on Thursday, July, 25th. The company provided earnings per share (EPS) guidance of $3.00-3.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.89. The company issued revenue guidance of $1.810-1.825 billion, compared to the consensus revenue estimate of $1.81 billion.

3 brokers have issued 12 month price objectives for West Pharmaceutical Services' shares. Their forecasts range from $112.16 to $122.00. On average, they anticipate West Pharmaceutical Services' share price to reach $117.08 in the next twelve months. This suggests that the stock has a possible downside of 15.9%. View Analyst Price Targets for West Pharmaceutical Services.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for West Pharmaceutical Services.

Media coverage about WST stock has been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. West Pharmaceutical Services earned a news sentiment score of -1.5 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for West Pharmaceutical Services.

Some companies that are related to West Pharmaceutical Services include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), Neogen (NEOG), ICU Medical (ICUI), Quidel (QDEL), Merit Medical Systems (MMSI), Atrion (ATRI), STAAR Surgical (STAA), Anika Therapeutics (ANIK), Cerus (CERS), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include Mcdonald's (MCD), Johnson & Johnson (JNJ), Nike (NKE), Stanley Black & Decker (SWK), PepsiCo (PEP), Lowe's Companies (LOW), Medtronic (MDT), AFLAC (AFL), Sherwin-Williams (SHW) and NVIDIA (NVDA).

West Pharmaceutical Services' stock is owned by a number of of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (0.80%), Rhumbline Advisers (0.33%), AMI Asset Management Corp (0.31%), Envestnet Asset Management Inc. (0.20%), Nisa Investment Advisors LLC (0.12%) and McCollum Christoferson Group LLC (0.10%). Company insiders that own West Pharmaceutical Services stock include Daniel Malone, Karen Flynn, Patrick J Zenner and William J Federici. View Institutional Ownership Trends for West Pharmaceutical Services.

WST stock was sold by a variety of institutional investors in the last quarter, including AMI Asset Management Corp, Rhumbline Advisers, First Citizens Bank & Trust Co., Pacer Advisors Inc., Grace & White Inc. NY, Virginia Retirement Systems ET AL, McCollum Christoferson Group LLC and Brinker Capital Inc.. View Insider Buying and Selling for West Pharmaceutical Services.

WST stock was bought by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Kistler Tiffany Companies LLC, Tuttle Tactical Management, Alberta Investment Management Corp, Riverbridge Partners LLC, Robeco Institutional Asset Management B.V., Nisa Investment Advisors LLC and Fox Run Management L.L.C.. View Insider Buying and Selling for West Pharmaceutical Services.

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WST stock can currently be purchased for approximately $139.17.

West Pharmaceutical Services has a market capitalization of $10.26 billion and generates $1.72 billion in revenue each year. The medical instruments supplier earns $206.90 million in net income (profit) each year or $2.81 on an earnings per share basis. West Pharmaceutical Services employs 7,700 workers across the globe.View Additional Information About West Pharmaceutical Services.

The official website for West Pharmaceutical Services is http://www.westpharma.com/.

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]